Rolling review for marketing authorisation applications

Document preview4 pages
Cover of Rolling review for marketing authorisation applications
Page 1 of 4

Download this document free

Get this document with your free trial. Choose from the full Complyzard library.

Try 1 month free30 days free, then $19/month. Trial terms apply. Card required. Cancel anytime.
Document information

Use the rolling review route when you want to submit your eCTD dossier in separate parts for pre-assessment instead of making a full consolidated document submission.

Adapted edition

Document type
Reference Guide
Format
DOCX
Pages
4
Language
English
Version
1.0
Updated
2026-09-17
Description

Use the rolling review route when you want to submit your eCTD dossier in separate parts for pre-assessment instead of making a full consolidated document submission. Consult the original guidance for current legal and operational details.

Contents
  • 1. Overview
  • 2. Eligibility
  • 3. How to apply
  • 4. Fees
  • 5. Assessment
  • 5.1 Pre-assessment of modules
  • 5.2 Before submission
  • 5.3 Pre-submission meeting
  • 5.4 Validation of applications (MAAs)
  • 5.5 Final phase assessment
  • 6. Appeals
  • 7. Publication
  • 8. Further information
Source and licence
Rolling review for marketing authorisation applications

Medicines and Healthcare products Regulatory Agency

AttributionMedicines and Healthcare products Regulatory Agency, ‘Rolling review for marketing authorisation applications’ (updated 11 March 2025), reused under the Open Government Licence v3.0.

ChangesNeutral text-only adaptation from the official GOV.UK Content API body: headings, paragraphs, ordered and unordered list items and clickable source-link destinations in an appendix preserved. Images, logos, page design, accessible-format request widgets and linked attachments excluded; normalised whitespace, invisible format marks and typography.

Version history
  • v1.017/09/2026
Report this document